1. GalNAc-T3 and MUC1, a combined predictor of prognosis and recurrence in solitary pulmonary adenocarcinoma initially diagnosed as malignant solitary pulmonary nodule (≤ 3 cm).
- Author
-
Xie Q, Li F, Zhao S, Guo T, Li Z, Fang L, Wang S, Liu W, and Gu C
- Subjects
- Adenocarcinoma of Lung genetics, Adenocarcinoma of Lung pathology, Aged, Aged, 80 and over, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Lung Neoplasms genetics, Lung Neoplasms pathology, Male, Middle Aged, Neoplasm Recurrence, Local genetics, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Predictive Value of Tests, Prognosis, Retrospective Studies, Polypeptide N-acetylgalactosaminyltransferase, Adenocarcinoma of Lung diagnosis, Biomarkers, Tumor analysis, Biomarkers, Tumor genetics, Gene Expression, Lung Neoplasms diagnosis, Mucin-1 analysis, Mucin-1 genetics, N-Acetylgalactosaminyltransferases analysis, N-Acetylgalactosaminyltransferases genetics, Neoplasm Recurrence, Local diagnosis, Solitary Pulmonary Nodule diagnosis
- Abstract
The significance of the polypeptide N-acetyl-galactosaminyl transferase-3 (GalNAc-T3) and mucin 1 (MUC1) in solitary pulmonary adenocarcinoma (SPA) initially diagnosed as malignant solitary pulmonary nodule (≤ 3 cm), especially as a combined predictor of prognosis and recurrence, was explored in this study. A retrospective analysis of 83 patients with SPA (≤ 3 cm), which revealed postoperative pathological diagnosis was lung adenocarcinoma after complete resection. Immunohistochemical staining was used to detect the expression of GalNAc-T3 and MUC1 in primary tumor specimens. The relationship between expression and various clinicopathological factors was analyzed, as well as the effects of patients' overall survival (OS) and disease-free survival (DFS). In all patients, GalNAc-T3 was highly expressed in 53 (63.9%) cases; MUC1 was highly expressed in 31 (37.3%) cases. The GalNAc-T3 expression was correlated with differentiation, pathological risk group, N stage, and TNM stage. The group with high GalNAc-T3 expression and low MUC1 expression (GalNAc-T3
Hig /MUC1Low ) is correlated to pathological differentiation and has a trend related to the TNM stage. The patients with better differentiation, lower pathological risk group, lower N stage, and GalNAc-T3 high expression had better overall survival, especially the GalNAc-T3Hig /MUC1Low group. Moreover, the moderate differentiation, N3 stage, and GalNAc-T3Hig /MUC1Low group were independent predictive factors for OS. Besides, patients with lower N stage, lower TNM stage, higher GalNAc-T3 expression got better disease-free survival (DFS), especially the GalNAc-T3Hig /MUC1Low group. The GalNAc-T3Hig /MUC1Low group was an independent predictive factor for DFS. In conclusion, GalNAc-T3 and MUC1 were combined predictors of prognosis and recurrence in SPA (≤ 3 cm).- Published
- 2020
- Full Text
- View/download PDF